Jump to content

  • Log in with Facebook Log in with Twitter Log in with Windows Live Log In with Google      Sign In   
  • Create Account

Submit your paper to J Biol Methods today!
- - - - -

Clinical Response Markers in Autoimmune Disease

  • Please log in to reply
No replies to this topic

#1 carole mcarthur

carole mcarthur


  • Members
  • Pip
  • 1 posts

Posted 29 July 2010 - 02:33 PM

I would like to develop a method using a small biopsy to evaluate clinical responses in patients with autoimmune disease. The biopsy tissue would be the target tissue destroyed by the autoimmune process but readily accessible and relatively non-invasive...the key goal is that, if successful, the method would avoid the use of DMARDS and associated morbidity before therapy.

I want to develop a strategy to determine feasibility of this but am bogged down in developing a logical approach.

The mechanism of tissue destruction in this model is unclear but appears to involve apoptosis. I can establish the intrinsic and extrinsic pathways in vitro in homologous target tissue cell lines and I can turn the extrinsic pathway off using estrogen. I have not tried to inhibit other pathways yet.

Any suggestions on this general idea?Email me

I wondered about first determining that both pathways exist in a biopsy of the target tissue and attempting to turn them on and off to replicate pathogenesis.

Home - About - Terms of Service - Privacy - Contact Us

©1999-2013 Protocol Online, All rights reserved.